| [1] |
LIANG Zongying, ZHAO Baoshan, ZHENG Jingxiong, HOU Jishen, SUN Guangrui..
Correlation of acetyltransferase KAT2A and survivin protein acetylation in esophageal cancer
[J]. Chinese Clinical Oncology, 2023, 28(01): 16-22.
|
| [2] |
QIU Sichong, XU Luyu, LI Liuning.
Construction and validation of prognostic nomogram for malignant meningioma based on SEER database
[J]. Chinese Clinical Oncology, 2023, 28(01): 30-37.
|
| [3] |
ZHAN Tianpeng, HE Wei, ZHANG Meng, TAO Yan, LU Jianzhong, FU Shengjun, LI Lanlan, ZHANG Jing, LIU Shanhui.
Clinical prognostic value and molecular mechanism of UBE2C gene in kidney renal clear cell carcinoma
[J]. Chinese Clinical Oncology, 2023, 28(01): 49-57.
|
| [4] |
XUE Luxin, ZHANG Zhifan, LIU Fangcen, WANG Xiaolu, WANG Qin, LIU Baorui, LI Rutian..
Current status and prospect of immune checkpoint inhibitors in treatment of advanced soft tissue sarcoma
[J]. Chinese Clinical Oncology, 2023, 28(01): 77-83.
|
| [5] |
CAI Huilong, YUAN Weiguang, SUN Huixin..
Prevalence and prevention strategies of cervical cancer in the world and China
[J]. Chinese Clinical Oncology, 2023, 28(01): 90-93.
|
| [6] |
LIU Delong, JIANG Suibin, GUO Dongming..
Experimental study of MALAT1 targeting
miR-205 and invasion of osteosarcoma
[J]. Chinese Clinical Oncology, 2018, 23(5): 385-390.
|